# A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy

> **NCT00555516** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Tri-Service General Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Breast Cancer
- Chemotherapy
- Neutropenia

## Interventions

- **OTHER:** EW02

## Key facts

- **NCT ID:** NCT00555516
- **Lead sponsor:** Tri-Service General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-11
- **Primary completion:** —
- **Final completion:** 2009-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2007-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00555516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00555516, "A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00555516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*